$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical drugs
Medical drugs
Medical drugs-Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Is Upatinib/Refu considered a targeted drug? What are its clinical applications?
2026-02-01 22:25:32
Check Details
Specifications and storage forms of bimetinib/bemetinib
2026-02-01 22:25:32
Check Details
Brief introduction and clinical overview of Teritusumab/Telicat
2026-02-01 22:25:32
Check Details
What type of drug is Quizartinib?
2026-02-01 22:25:32
Check Details
What are the side effects of pomalidomide capsules?
2026-02-01 22:25:32
Check Details
How long does it take to see the effects of Lapatinib?
2026-02-01 22:25:32
Check Details
Which company's product is filgotinib and what is the market feedback?
2026-02-01 22:25:32
Check Details
What is the therapeutic effect after taking Selumetinib/Cosaiyou?
2026-02-01 22:25:32
Check Details
What are the common side effects of Lorlatinib/Lorlatinib (Borina)?
2026-02-01 22:25:32
Check Details
How many pills does a box of Cabozantinib contain?
2026-02-01 22:25:32
Check Details
Are there any generic versions of Bosutinib?
2026-02-01 22:25:32
Check Details
Who are the original manufacturers of Nintedanib? Is the quality guaranteed?
2026-02-01 22:25:32
Check Details
1
2
...
2418
2419
2420
2421
2422
2423
2424
...
2439
2440
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
ROS and Cancer: The Potential of Natural Antioxidants
2
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment
3
LPCAT3: The Key Player in MASH Progression to Hepatocellular Carcinoma
4
Breztri Aerosphere Approved by US FDA for Maintenance Treatment of Asthma in Patients Aged 12 Years and Older
5
Datopotamab Deruxtecan as First-Line Treatment for Advanced Triple-Negative Breast Cancer: Full Interpretation of the Phase III TROPION-Breast02 Trial
6
Olaparib Plus Pembrolizumab Maintenance Therapy for Metastatic Pancreatic Cancer: Findings from the POLAR Phase II Basket Trial
7
From Causes to Treatments—Exploring Medical Breakthroughs
8
IRX4 Transcription Factor: New Research Insights on Colorectal Cancer Treatment Targets
9
New Research Progress on Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Tumor Relationship
10
Tyrosine Kinase and JAK Inhibitors May Increase Keratinocyte Carcinoma Risk: New Research Reveals Drug Safety Findings
11
CLISGen Database: A New Tool for Cell Line Selection in Cancer Genetic Variation Research
12
RAS Targeted Therapy Resistance Breakthrough: mTORC1 is Key, Dalifarnib Combination Therapy Brings Hope